Cipla to acquire US-based InvaGen Pharmaceuticals and Exelan Pharmaceuticals
Signs agreements to acquire 100 per cent of generic businesses in the US for $550 million Cipla's UK arm, Cipla EU has entered…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.